I-Mab Presents Positive Givastomig Phase 1b Dose Escalation Data in Combination with Immunochemotherapy in Patients with 1L Gastric Cancers at ESMO GI 2025 — Neutral
IMAB GlobeNewsWire — July 02, 2025Data show confirmed ORR of 83% (10/12) at doses selected for ongoing expansion study Median follow-up of 9.0 months as of the updated data cutoff Responses observed in patients with low PD-L1 and/or CLDN18.2 expression Company to host investor event on Tuesday, July 8 th ROCKVILLE, Md., July 02, 2025 (GLOBE NEWSWIRE) -- I-Mab (NASDAQ: IMAB) (the Company), a U.S.-based, global biotech company, focused on the development of precision immuno-oncology agents for the treatment of cancer, today announced the presentation of positive Phase 1b combination data for givastomig, in combination with nivolumab and mFOLFOX6, at the European Society for Medical …
DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Organon — Neutral
OGN GlobeNewsWire — July 02, 2025Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $75,000 In Organon To Contact Him Directly To Discuss Their Options
ROSEN, A HIGHLY RECOGNIZED LAW FIRM, Encourages Fortrea Holdings, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – FTRE — Neutral
FTRE GlobeNewsWire — July 02, 2025NEW YORK, July 02, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Fortrea Holdings, Inc. (NASDAQ: FTRE) between July 3, 2023 and February 28, 2025, both dates inclusive (the “Class Period”), of the important August 1, 2025 lead plaintiff deadline.
ValueWorks founder Charles Lemonides: Rivian is one of the longterm winners in auto space — Positive
RIVN CNBC Television — July 02, 2025Charles Lemonides, ValueWorks founder, joins CNBC's 'Squawk on the Street' to discuss why he sees Rivian as a value pick, why the company may be poised to withstand competition from Chinese EV makers, and more.
Amazon unveils its one millionth robot Transcript: CAROLINE WOODS: Just weeks after CEO Andy Jassy said artificial intelligence would lead to Amazon having a smaller workforce - the company unveiled its one millionth robot. Amazon is the largest manufacturer and operator of mobile robotics in the world.
FTRE Shareholders Have the Right to Lead the Fortrea Holdings, Inc. Securities Lawsuit - Contact the DJS Law Group Before the Final Deadline - FTRE — Neutral
FTRE PRNewsWire — July 02, 2025LOS ANGELES , July 2, 2025 /PRNewswire/ -- The DJS Law Group reminds investors of a class action lawsuit against Fortrea Holdings, Inc. ("Fortrea" or "the Company") (NASDAQ: FTRE) for violations of the federal securities laws. Shareholders who purchased the Company's securities between July 3, 2023 and February 28, 2025, inclusive (the "Class Period"), are encouraged to contact the firm before August 1, 2025.
Attention Long-Term Virtu Financial Inc. (NYSE: VIRT) Shareholders: Grabar Law Office Investigates Claims on Your Behalf as SEC and Virtu Reach Tentative Settlement — Neutral
VIRT GlobeNewsWire — July 02, 2025PHILADELPHIA, July 02, 2025 (GLOBE NEWSWIRE) -- A federal securities fraud class action alleging that Virtu Financial Inc. (NYSE: VIRT), and certain of its officers failed to make proper disclosures to investors has survived a motion to dismiss and the Securities and Exchange Commission action against Virtu has reached a tentative settlement.
The U.S. Food and Drug Administration has approved Regeneron's cancer therapy, the company said on Wednesday, providing another treatment option for patients with a recurring and common form of blood cancer.
Can Disciplined Cost Management Fuel ExxonMobil's Future? — Positive
XOM Zacks Investment Research — July 02, 2025XOM targets breakeven at $30/barrel by 2030 while slashing $12.7B in costs, fueling resilience amid price swings.
Ryanair Issues Impressive Traffic Numbers for June 2025 — Positive
RYAAY Zacks Investment Research — July 02, 2025RYAAY reports June 2025 load factor of 95%, which remained flat on a year-over-year basis and sequentially.
Here's Why You Should Retain Genpact Stock in Your Portfolio Now — Positive
G Zacks Investment Research — July 02, 2025G earns top sustainability honors, and boosts AI innovation with the new AP Suite and XponentL buyout while raising dividends and buybacks.
4 Stocks to Watch in a Rapidly Shifting Outpatient Home Health Space — Positive
DGX DVA EHC PNTG Zacks Investment Research — July 02, 2025An aging global population and AI dominance are likely to drive the Zacks Medical - Outpatient and Home Healthcare industry despite the macroeconomic challenges. DGX, EHC, DVA and PNTG are well-poised to gain.
DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Fortrea Holdings — Neutral
FTRE GlobeNewsWire — July 02, 2025Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In Fortrea To Contact Him Directly To Discuss Their Options
Constellation Brands reports Q1 miss, hints at pullback in Hispanic consumer base — Negative
STZ CNBC Television — July 02, 2025CNBC's Brandon Gomez joins 'Squawk on the Street' with the latest earnings number from Constellation Brands.
General Dynamics Looking Big And Beautiful With Defense Spending Likely To Top $1 Trillion — Positive
GD Seeking Alpha — July 02, 2025General Dynamics is well-positioned to benefit from rising U.S. and NATO defense spending, thanks to its diversified portfolio. Despite management concerns at a government munitions facility and potential political risks, GD's broad exposure and strong fundamentals provide resilience against sector-specific headwinds. Valuation is reasonable with a PE below sector median, solid dividend growth, and revenue momentum; I see GD as a reliable income and growth play.
Abbott Sees Upside on Diagnostics Growth, FreeStyle Libre Expansion — Positive
ABT Zacks Investment Research — July 02, 2025ABT stock surges 21.7% year to date on CGM sales growth and robust diagnostics demand, even as FX and macro risks weigh on forecasts.
MU's Embedded Business Grows 20%: Is AI in Industrial Gaining Steam? — Positive
MU Zacks Investment Research — July 02, 2025Micron's Embedded unit sales jumped 20% sequentially in Q3 as AI gains traction in industrial and automotive markets, driving fresh momentum.
Embraer Wins $4B Scandinavian Airlines Order to Supply 55 E195-E2 Jets — Positive
ERJ Zacks Investment Research — July 02, 2025ERJ lands a $4B SAS deal for 55 fuel-efficient E195-E2 jets, boosting its backlog and future revenue potential.
Here's Why You Should Add HealthEquity Stock to Your Portfolio Now — Positive
HQY Zacks Investment Research — July 02, 2025HQY's sustained strength in HSAs raises optimism about the stock.
VEEV Integrates GenAI in Vault Platform to Drive Workflow Automation — Positive
VEEV Zacks Investment Research — July 02, 2025Veeva's new AI layer in Vault boosts automation and deepens pharma reliance, sharpening its edge in life sciences tech.
